We are live on ! Find out more
B

Barings Portfolio holdings

AUM $6.19B
1-Year Est. Return 16.5%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+16.5%
3 Year Est. Return
+50.95%
5 Year Est. Return
+53.21%
10 Year Est. Return
+287.68%
AUM
$6.19B
AUM Growth
+$766M
Cap. Flow
+$768M
Cap. Flow %
12.4%
Top 10 Hldgs %
75.93%
Holding
198
New
29
Increased
49
Reduced
49
Closed
19

Sector Composition

Rank Sector Weight
1 Financials 3.99%
2 Materials 3.46%
3 Energy 3.15%
4 Consumer Discretionary 1.78%
5 Healthcare 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
176
Goldman Sachs
GS
$314B
-234
Closed -$206K
IBM icon
177
IBM
IBM
$200B
-686
Closed -$203K
IBN icon
178
ICICI Bank
IBN
$107B
-10,724
Closed -$320K
IVW icon
179
iShares S&P 500 Growth ETF
IVW
$73.1B
-269,017
Closed -$33.2M
MCD icon
180
McDonald's
MCD
$190B
-2,045
Closed -$625K
MRK icon
181
Merck
MRK
$315B
-2,011
Closed -$212K
NBR icon
182
Nabors Industries
NBR
$1.24B
-179,841
Closed -$9.77M
ORCL icon
183
Oracle
ORCL
$364B
-1,085
Closed -$211K
PAAS icon
184
Pan American Silver
PAAS
$17.6B
-138,681
Closed -$7.19M
PBR icon
185
Petrobras
PBR
$116B
-73,545
Closed -$872K
PCH
186
DELISTED
PotlatchDeltic
PCH
-43,064
Closed -$1.71M
SHW icon
187
Sherwin-Williams
SHW
$81.7B
-7,091
Closed -$2.3M
SUSC icon
188
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
-90,424
Closed -$2.11M
TJX icon
189
TJX Companies
TJX
$171B
-2,897
Closed -$445K
TMO icon
190
Thermo Fisher Scientific
TMO
$198B
-392
Closed -$227K
NBIS
191
Nebius Group N.V.
NBIS
$45.1B
-90,661
Closed
MICC
192
The Magnum Ice Cream Company N.V.
MICC
$11.4B
-33,796
Closed -$535K

Similar funds

Barings's Q1 2026 Portfolio in Review

As of Q1 2026, Barings held 198 positions worth $6.19B, up 14% from $5.43B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Barings deployed $768M of net new capital in Q1 2026, opening 29 new positions and adding to 49 existing holdings. Its largest new stake was AstraZeneca: 143,032 shares worth $27.8M.

By sector, the portfolio is most concentrated in Financials at 4% of assets, down from 5% a quarter earlier, followed by Materials and Energy.

On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $35.8M trimmed.

  • Barings's largest Q1 2026 buy was AstraZeneca: 143,032 shares worth $27.8M.
  • Barings added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2026, an estimated $644M increase.
  • Barings's biggest Q1 2026 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $35.8M.
  • Barings fully exited iShares S&P 500 Growth ETF in Q1 2026, selling an estimated $33.2M.
  • Barings's ten largest holdings make up 76% of its $6.19B portfolio in Q1 2026.
  • Barings opened 29 new positions and closed 19 in Q1 2026.
  • Barings's portfolio value rose 14% quarter-over-quarter to $6.19B.

Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.